South Africa scraps AstraZeneca, pivots to Johnson & Johnson vaccine

South Africa has offered its stock of Oxford-AstraZeneca Covid-19 vaccines to the African Union, a senior health official said, as the country pivots to using shots developed by Johnson & Johnson instead. Read Full Story